Clinical Research Resource Review Process

What's the Clinical Research Resource Review Process?

Effective July 1, 2022, all Departments in the Medical School will be required to implement a departmentally-based resource review process for all research studies that require IRB approval, in which the Principal Investigator has a tenure home in a Medical School department; at least a 50% appointment in a Medical School department; or if the study requires Medical School resources to advance the project (e.g., faculty, staff, facilities, equipment, funding). This is inclusive of all study types (e.g. retrospective chart review or registry; prospective, observational or treatment; sponsored or non-sponsored; investigator-initiated or business and industry-sponsored) planned for submission for human subjects protection review by either an internal or external IRB.

What are the Departmental Requirements?

The Medical School requirements for these departmentally-based processes are intended to give each department flexibility, while ensuring each process minimally assesses each protocol for the following:

  • 1. Staffing Effort: The PI must allocate adequate effort to lead the study, and the total percent effort across all team members must be enough to complete the study.
  • 2. Protocol Funding: The PI must identify the specific funding source/s they will use to complete the study. The funding source/s must be adequate to cover all study costs; TBD is not acceptable. Department leadership (Department Chairs, Vice Chairs for Research, or Division Directors) should sign off on any departmental costs. If a study is over-budget or not fully funded, the Department Chairs (or their designee) signature assures the department will cover those costs.
  • 3. Participant Recruitment: The PI must document a plan that demonstrates an ability to recruit and enroll the intended study population.
  • 4. Research Priorities: The Department Chair (or their designee) confirms the protocol fits into the research goals of the Department.

The department must designate at a minimum, two leadership approvers (e.g. Division Directors, Department Chairs or Vice Chairs for Research) to sign off on the resource review for the protocol prior to the PI submitting the protocol to the IRB.  Their signature assures adequate resources are available for the study.

What Needs to Be Submitted to the Medical School and When?

By June 10th, each department will be expected to submit a one-page, high-level outline via a REDCap survey that describes their own departmentally-developed review and approval process. The Medical School Research Office will review each process and provide feedback via email to the department designated contact shared at initial submission. Please contact Mahrya Johnson ( with any questions.

What if I Have Questions?

The Medical School Research Office has started a Frequently Asked Questions (FAQ) document for commonly discussed topics. Please contact Mahrya Johnson ( with any questions.

How Will We Access the Efficiency of This Process?

The effectiveness of this process will be assessed over time.  The Research Office is currently working through the metrics data and reporting options. Our goal is to provide a baseline report to each department by July 1st, 2022.  The Research Office anticipates departments will use these data, and with time, adapt their processes during the first year of implementation, while still assessing the four requirements noted above, to ensure their resource review processes are working to improve “time to…” metrics.